INTELLECTUAL PROPERTY

  • ANL - 101

    AD/PD/MCI therapeutic agent

    • 등록

      KOREA (December, 2017)
      USA (July, 2020)
      CHINA (June, 2021)

    • 출원

      CHINA, PCT(Jun, 2016 )

  • ANL - 104

    Agent for Degenerative Obesity & Diabetes

    • 등록

      In Korea(January, 2021)

    • 출원

      In Korea(September, 2017)

  • ANL-105

    Agent for Epilepsy

    • 등록

      In Korea (April, 2021)

    • 출원

      In Korea (December, 2017)